Rosiglitazone Did Not Induce Acute Kidney Injury in Normocholesterolemic Rats Despite Reduction in Glomerular Filtration Rate
Background/Aims: Rosiglitazone (RGL) has been used to ameliorate lipids homeostasis and also to treat inflammatory diseases. However, RGL may reduce renal blood flow and glomerular filtration rate (GFR) predisposing to acute kidney injury (AKI). We investigated whether the treatment with RGL induces...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Karger Publishers
2014-04-01
|
| Серии: | Kidney & Blood Pressure Research |
| Предметы: | |
| Online-ссылка: | http://www.karger.com/Article/FullText/355767 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
